Assessing CMMI’s proposals on Medicaid payment for cell and gene therapies
Brookings,
Recent years have seen the arrival of a wave of new therapies that use living cells or genetic material to treat disease, which…
State of the Cell and Gene Therapy Market
Pharma's Almanac,
Numerous Commercial Advances By mid-2022, there were eight cell and gene therapies approved by the U.S.
IP or Not IP: That Is the Question for Cell and Gene Therapy Sector
GEN,
Cell and gene therapy manufacturing may never be standardized but the whole industry would gain if firms collaborated to…
Regenerative medicine as a disruptive technology: implications for manufacturing
BioInsights,
Introduction Regenerative medicine (RM), which promises to cure disease and respond to currently unmet medical needs [ 1 ], is…
Interview: As Gene and Cell Therapies Grow, Reimbursement Model Needs to Change
Biospace,
Although the advent of cell and gene therapies is revolutionizing medicine, it is arguable that the therapies that have been…